French psychiatric caregivers' perceptions of psychedelics: A national survey.
L'Encephale October 16, 2026 Anne Buot, Jean-Del Burdairon, Luc Mallet et al.
The use of psychedelic substances such as LSD, psilocybin, and dimethyltryptamine is currently being re-evaluated for their therapeutic potential in psychiatry. While international clinical research had started in the 2010s, France only initiated its first psychedelic trials in 2024. This study aimed to explore the knowledge, perceptions, and attitudes of French mental health professionals...
DOI: 10.1016/j.encep.2026.06.015 (opens in new tab)
Full text (opens in new tab)
Ketamine
Kétamine
Mental health
Psychedelic drugs
+4